Partnerships in Personalized Medicine Conference - San Mateo, California

This conference program will provide a platform for both diagnostic and therapeutic companies to come together to discuss the challenges and inherent opportunities that exist in partnerships established to enhance personalized medicine and companion diagnostics.

Through case studies that highlight the successes in development, regulatory hurdles and commercialization of these companion tests, to round-table discussions that delve into specific therapeutic areas such as cancer, heart disease and diabetes.

Speaking companies include: Head of Technology Transactions for Clinical Biomarkers & for Pharmacodiagnostics for Bristol-Myers Squibb, Global Head Regulatory Affairs at Novartis, CEO of Arcxis Biotechnologies and many more…

Further Information: http://www.q1productions.com/eventPages/event_LSCONF-2020.php